Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q2

2269.TEDINET S100PI81
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥517.5bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥1.01T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥500.7bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥43.2bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥50.3bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥43.9bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥94.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥51.8bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥48.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥55.2bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥33.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥87.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥36.6bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥34.9bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥40.0bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥1.18Tat 2022-09-30Cons.Assets
Total assets¥1.12Tat 2022-03-31Cons.Assets
Total assets¥1.14Tat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥426.8bnat 2022-09-30Cons.Liabilities
Total liabilities¥404.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥757.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥713.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥695.7bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥92.1bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥67.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥88.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥80.9bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥39.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥25.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥127.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥61.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥26.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥27.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥35.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥20.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥77.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥14.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥237.042022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.312022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥607.242021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥252.542021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥166.442021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio60.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio57.4%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥292m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥292m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥786m
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-09-30¥420.6bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-09-30¥420.4bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥278m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.3bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2022-04-01 → 2022-09-30¥97.2bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2022-04-01 → 2022-09-30¥97.2bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥13m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2022-04-01 → 2022-09-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥517.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥517.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥292m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥44.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥468m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥468m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥534m
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2021-04-01 → 2021-09-30¥409.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2021-04-01 → 2021-09-30¥408.8bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥254m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2021-04-01 → 2021-09-30¥39.6bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2021-04-01 → 2021-09-30¥92.1bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2021-04-01 → 2021-09-30¥91.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥214m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2021-04-01 → 2021-09-30¥11.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥501.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥500.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥468m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥50.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Purchase of property plant and equipment inv cfPrior1YTDDuration-45775000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-32002000000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-2302000000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-1592000000JPY
Proceeds from sales of property plant and equipment and intangible assets inv cfPrior1YTDDuration1709000000JPY
Proceeds from sales of property plant and equipment and intangible assets inv cfCurrentYTDDuration7884000000JPY
Subsidies received inv cfPrior1YTDDuration4200000000JPY
Subsidies received inv cfCurrentYTDDuration－JPY
Purchase of investment securities inv cfPrior1YTDDuration-53000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-60000000JPY
Proceeds from sales of investment securities inv cfPrior1YTDDuration5896000000JPY
Proceeds from sales of investment securities inv cfCurrentYTDDuration348000000JPY
Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration2300000000JPY
Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration1944000000JPY
Other net inv cfPrior1YTDDuration-1564000000JPY
Other net inv cfCurrentYTDDuration-2494000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-35590000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-25972000000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration28706000000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration36447000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-10270000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-2165000000JPY
Proceeds from issuance of bonds fin cfPrior1YTDDuration9952000000JPY
Proceeds from issuance of bonds fin cfCurrentYTDDuration－JPY
Decrease increase in treasury stock fin cfPrior1YTDDuration153000000JPY
Decrease increase in treasury stock fin cfCurrentYTDDuration506000000JPY
Cash dividends paid fin cfPrior1YTDDuration-12309000000JPY
Cash dividends paid fin cfCurrentYTDDuration-12653000000JPY
Dividends paid to non controlling interests fin cfPrior1YTDDuration-949000000JPY
Dividends paid to non controlling interests fin cfCurrentYTDDuration-1430000000JPY
Other net fin cfPrior1YTDDuration-658000000JPY
Other net fin cfCurrentYTDDuration-435000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration14625000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration20269000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration1626000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration4416000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration41847000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration23874000000JPY
Cash and cash equivalentsPrior2YearInstant39011000000JPY
Cash and cash equivalentsPrior1YearInstant64872000000JPY
Increase in cash and cash equivalents from newly consolidated subsidiary ccePrior1YTDDuration16000000JPY
Increase in cash and cash equivalents from newly consolidated subsidiary cceCurrentYTDDuration－JPY
Cash and cash equivalentsPrior1QuarterInstant80876000000JPY
Cash and cash equivalentsCurrentQuarterInstant88746000000JPY
Discounted trade notes receivablePrior1YearInstant－JPY
Discounted trade notes receivableCurrentQuarterInstant9000000JPY
Trade notes receivable transferred by endorsementPrior1YearInstant37000000JPY
Trade notes receivable transferred by endorsementCurrentQuarterInstant52000000JPY
Promotion expenses sgaPrior1YTDDuration8283000000JPY
Promotion expenses sgaCurrentYTDDuration9190000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass